Sugi Predict

Sugi Predict / Compounds / SCHEMBL4792199

SCHEMBL4792199

SCHEMBL4792199

Cn1cnc2c(Cl)ncc(C(=O)O)c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 1/20 0.41
▸ PDE4B Q07343 1/20 0.41
▸ PDE4C Q08493 1/20 0.41
▸ PDE4D Q08499 1/20 0.41
▸ NR3C1 P04150 2/20 0.38
▸ EGLN1 Q9GZT9 1/20 0.36
▸ HTT P42858 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ HAVCR2 Q8TDQ0 1/20 0.34
▸ GABRP O00591 2/20 0.33
▸ GABRD O14764 2/20 0.33
▸ GABRA1 P14867 2/20 0.33
▸ GABRB1 P18505 2/20 0.33
▸ GABRG2 P18507 2/20 0.33
▸ GABRB3 P28472 2/20 0.33
▸ GABRA5 P31644 2/20 0.33
▸ GABRA3 P34903 2/20 0.33
▸ GABRA2 P47869 2/20 0.33
▸ GABRB2 P47870 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4791366 0.80 BAZ2B (0.44) HTTLMNASMN1; SMN2GAAKDM4E
SCHEMBL4791767 0.77 CNR1 (0.47) HTTLMNASMN1; SMN2KDM4EHPGD
SCHEMBL17963136 0.75 NR3C1 (0.56) NR3C1SMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL30366858 0.73 CYP3A4 (0.39) NR3C1LMNASMN1; SMN2HAVCR2GABRP
SCHEMBL3990597 0.73 CYP3A4 (0.39) NR3C1LMNASMN1; SMN2HAVCR2GABRP
SCHEMBL25241852 0.73 CDK1 (0.35) PDE4APDE4BPDE4CPDE4DLMNA
SCHEMBL4793552 0.72 CNR2 (0.50) LMNASMN1; SMN2GFERHPGDKMT2A
SCHEMBL14051369 0.72 SRC (0.41) PDE4APDE4BPDE4CPDE4DLMNA
SCHEMBL14051368 0.72 PTGER4 (0.46) PDE4BTDP1
Hydrochloric Acid SCHEMBL4793003 0.71 PTGER4 (0.45) PDE4BTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008116816-A1 COMBINATION OF CB2 LIGAND AND PARACETAMOL GLAXO GROUP LIMITED (GB) 2008-10-02 — — WO disclosed
US-20080221097-A1 Imidazopyridine Derivatives as Cannabinoid Receptor Ligands GLAXO GROUP LIMITED 2008-09-11 — — US disclosed
US-20080221097-A1 Imidazopyridine Derivatives as Cannabinoid Receptor Ligands GLAXO GROUP LIMITED 2008-09-11 — — US disclosed
US-20080221097-A1 Imidazopyridine Derivatives as Cannabinoid Receptor Ligands GLAXO GROUP LIMITED 2008-09-11 — — US disclosed
EP-1912985-A1 IMIDAZOPYRIDINE DERIVATIVES AS CANNABINOID RECEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2008-04-23 — — EP disclosed
WO-2007017237-A1 IMIDAZOPYRIDINE DERIVATIVES AS CANNABINOID RECEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2007-02-15 — — WO disclosed
WO-2007017237-A1 IMIDAZOPYRIDINE DERIVATIVES AS CANNABINOID RECEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2007-02-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221097-A1 Imidazopyridine Derivatives as Cannabinoid Receptor Ligands CNR1, CNR2, TRPV1 PDE4A 1129/4885PDE4B 1507/4885PDE4C 1860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.